<DOC>
	<DOCNO>NCT01889745</DOCNO>
	<brief_summary>This study design multiple dose dose escalation study</brief_summary>
	<brief_title>A Phase I Clinical Study Safety , Tolerability Pharmacokinetics HX-1171 Healthy Male Subjects .</brief_title>
	<detailed_description>A Phase I Clinical Study , Randomized , Single-blind , Placebo-controlled , Single Dose Escalation Study Safety , Tolerabiluty , Pharmacokinetics HX-1171 Healthy Male Subjects</detailed_description>
	<criteria>Adult male age 20 40 year screen . Be able comply requirement study . Subject must provide write informed consent prior study participation . History presence liver , kidney , nervous system disease , respiratory disorder , endocrinological disorder , hematooncologic , cardiovascular psychiatric gastrointestinal disorder . History known hypersensitivity drug include HX1171 .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>